BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kura B, Kalocayova B, Devaux Y, Bartekova M. Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection. Int J Mol Sci 2020;21:E700. [PMID: 31973111 DOI: 10.3390/ijms21030700] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Tanase DM, Gosav EM, Ouatu A, Badescu MC, Dima N, Ganceanu-Rusu AR, Popescu D, Floria M, Rezus E, Rezus C. Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI). Life (Basel) 2021;11:1057. [PMID: 34685428 DOI: 10.3390/life11101057] [Reference Citation Analysis]
2 Barbalata T, Zhang L, Dulceanu MD, Stancu CS, Devaux Y, Sima AV, Niculescu LS; EU-CardioRNA COST Action CA17129. Regulation of microRNAs in high-fat diet induced hyperlipidemic hamsters. Sci Rep 2020;10:20549. [PMID: 33239653 DOI: 10.1038/s41598-020-77539-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mir R, Elfaki I, Khullar N, Waza AA, Jha C, Mir MM, Nisa S, Mohammad B, Mir TA, Maqbool M, Barnawi J, Albalawi SO, Abu-Duhier FM. Role of Selected miRNAs as Diagnostic and Prognostic Biomarkers in Cardiovascular Diseases, Including Coronary Artery Disease, Myocardial Infarction and Atherosclerosis. J Cardiovasc Dev Dis 2021;8:22. [PMID: 33669699 DOI: 10.3390/jcdd8020022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Cong L, Xie X, Liu S, Xiang L, Fu X. Genistein promotes M1 macrophage apoptosis and reduces inflammatory response by disrupting miR-21/TIPE2 pathway. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.05.009] [Reference Citation Analysis]
5 Lai JJ, Chau ZL, Chen SY, Hill JJ, Korpany KV, Liang NW, Lin LH, Lin YH, Liu JK, Liu YC, Lunde R, Shen WT. Exosome Processing and Characterization Approaches for Research and Technology Development. Adv Sci (Weinh) 2022;9:e2103222. [PMID: 35332686 DOI: 10.1002/advs.202103222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Tocchetti CG, Ameri P, de Boer RA, D’alessandra Y, Russo M, Sorriento D, Ciccarelli M, Kiss B, Bertrand L, Dawson D, Falcao-pires I, Giacca M, Hamdani N, Linke WA, Mayr M, van der Velden J, Zacchigna S, Ghigo A, Hirsch E, Lyon AR, Görbe A, Ferdinandy P, Madonna R, Heymans S, Thum T. Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. Cardiovascular Research 2020;116:1820-34. [DOI: 10.1093/cvr/cvaa222] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
7 Wang B, Wang H, Zhang M, Ji R, Wei J, Xin Y, Jiang X. Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies. J Cell Mol Med 2020;24:7717-29. [PMID: 32536032 DOI: 10.1111/jcmm.15479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Hosseini M, Sahebi R, Aghasizadeh M, Yazdi DF, Salaribaghoonabad R, Godsi A, Soflaei SS, Mousavitaherabad SP, Ahmadihoseini A, Bajgiran MM, Ferns GA, Darban RA, Mobarhan MG. Investigating the predictive value of microRNA21 as a biomarker in induced myocardial infarction animal model. Gene Reports 2022. [DOI: 10.1016/j.genrep.2022.101578] [Reference Citation Analysis]
9 Jenike AE, Halushka MK. miR-21: a non-specific biomarker of all maladies. Biomark Res 2021;9:18. [PMID: 33712063 DOI: 10.1186/s40364-021-00272-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Guo H, Zhao X, Su H, Ma C, Liu K, Kong S, Liu K, Li H, Chang J, Wang T, Guo H, Wei H, Fu Z, Lv X, Li Y. miR-21 is upregulated, promoting fibrosis and blocking G2/M in irradiated rat cardiac fibroblasts. PeerJ 2020;8:e10502. [PMID: 33354435 DOI: 10.7717/peerj.10502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ge L, Fan Y, Fu L, Guo M, Cao P, Peng C, Wu L, Han L, Wu H. YQHX Alleviates H/R-Induced Cardiomyocyte Apoptosis by Downregulating miR-1. Evid Based Complement Alternat Med 2021;2021:4852406. [PMID: 34765002 DOI: 10.1155/2021/4852406] [Reference Citation Analysis]
12 Mariani M, Castagna C, Boccia S, Pastorino R. The Prognostic Role of Micro-RNAs in Head and Neck Cancers: An Umbrella Review. J Pers Med 2021;11:821. [PMID: 34442465 DOI: 10.3390/jpm11080821] [Reference Citation Analysis]
13 Lu P, Ding F, Xiang YK, Hao L, Zhao M. Noncoding RNAs in Cardiac Hypertrophy and Heart Failure. Cells 2022;11:777. [DOI: 10.3390/cells11050777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liu S, Guo X, Zhong W, Weng R, Liu J, Gu X, Zhong Z. Circulating MicroRNA Expression Profiles in Patients with Stable and Unstable Angina. Clinics (Sao Paulo) 2020;75:e1546. [PMID: 32667489 DOI: 10.6061/clinics/2020/e1546] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Marinescu MC, Lazar AL, Marta MM, Cozma A, Catana CS. Non-Coding RNAs: Prevention, Diagnosis, and Treatment in Myocardial Ischemia-Reperfusion Injury. Int J Mol Sci 2022;23:2728. [PMID: 35269870 DOI: 10.3390/ijms23052728] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Spinka G, Bartko PE, Pavo N, Freitag C, Zlabinger K, Prausmüller S, Arfsten H, Heitzinger G, Mascherbauer J, Hengstenberg C, Gyöngyösi M, Hülsmann M, Goliasch G. Secondary mitral regurgitation-Insights from microRNA assessment. Eur J Clin Invest 2021;51:e13381. [PMID: 32780418 DOI: 10.1111/eci.13381] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Szwed K, Szwed M, Kozakiewicz M, Karłowska-Pik J, Soja-Kukieła N, Bartoszewska A, Borkowska A. Circulating MicroRNAs and Novel Proteins as Potential Biomarkers of Neurological Complications after Heart Bypass Surgery. J Clin Med 2021;10:3091. [PMID: 34300256 DOI: 10.3390/jcm10143091] [Reference Citation Analysis]
18 Scolari FL, Faganello LS, Garbin HI, Piva E Mattos B, Biolo A. A systematic review of microRNAs in patients with hypertrophic cardiomyopathy. Int J Cardiol 2021;327:146-54. [PMID: 33212095 DOI: 10.1016/j.ijcard.2020.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Jakubik D, Fitas A, Eyileten C, Jarosz-Popek J, Nowak A, Czajka P, Wicik Z, Sourij H, Siller-Matula JM, De Rosa S, Postula M. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics. Cardiovasc Diabetol 2021;20:55. [PMID: 33639953 DOI: 10.1186/s12933-021-01245-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Nemcekova V, Kmecova Z, Bies Pivackova L, Goncalvesova E, Krenek P, Doka G, Klimas J. Hematocrit-Related Alterations of Circulating microRNA-21 Levels in Heart Failure Patients with Reduced Ejection Fraction: A Preliminary Study. Genet Test Mol Biomarkers 2021;25:302-6. [PMID: 33877895 DOI: 10.1089/gtmb.2020.0277] [Reference Citation Analysis]
21 Ferenczyová K, Kindernay L, Vlkovičová J, Kaločayová B, Rajtík T, Barteková M. Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart. Antioxidants (Basel) 2021;10:1390. [PMID: 34573022 DOI: 10.3390/antiox10091390] [Reference Citation Analysis]
22 Park JH, Kho C. MicroRNAs and Calcium Signaling in Heart Disease. Int J Mol Sci 2021;22:10582. [PMID: 34638924 DOI: 10.3390/ijms221910582] [Reference Citation Analysis]
23 Meng Q, Zhang J, Zhong J, Zeng D, Lan D. Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy. Front Neurol 2022;13:921785. [PMID: 35873767 DOI: 10.3389/fneur.2022.921785] [Reference Citation Analysis]
24 Hänninen M, Jäntti T, Tolppanen H, Segersvärd H, Tarvasmäki T, Lassus J, Vausort M, Devaux Y, Sionis A, Tikkanen I, Harjola VP, Lakkisto P, For The CardShock Study Group. Association of miR-21-5p, miR-122-5p, and miR-320a-3p with 90-Day Mortality in Cardiogenic Shock. Int J Mol Sci 2020;21:E7925. [PMID: 33114482 DOI: 10.3390/ijms21217925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
25 Khudiakov AA, Panshin DD, Fomicheva YV, Knyazeva AA, Simonova KA, Lebedev DS, Mikhaylov EN, Kostareva AA. Different Expressions of Pericardial Fluid MicroRNAs in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Ischemic Heart Disease Undergoing Ventricular Tachycardia Ablation. Front Cardiovasc Med 2021;8:647812. [PMID: 33816578 DOI: 10.3389/fcvm.2021.647812] [Reference Citation Analysis]
26 Galluzzo A, Gallo S, Pardini B, Birolo G, Fariselli P, Boretto P, Vitacolonna A, Peraldo-Neia C, Spilinga M, Volpe A, Celentani D, Pidello S, Bonzano A, Matullo G, Giustetto C, Bergerone S, Crepaldi T. Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing. ESC Heart Fail 2021;8:2907-19. [PMID: 33934544 DOI: 10.1002/ehf2.13371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Kura B, Kalocayova B, Szeiffova Bacova B, Fulop M, Sagatova A, Sykora M, Andelova K, Abuawad Z, Slezak J. The effect of selected drugs on the mitigation of myocardial injury caused by gamma radiation. Can J Physiol Pharmacol 2021;99:80-8. [PMID: 33438486 DOI: 10.1139/cjpp-2020-0323] [Reference Citation Analysis]
28 Khan H, Gamble D, Mezincescu A, Abbas H, Rudd A, Dawson D. A systematic review of biomarkers in Takotsubo syndrome: A focus on better understanding the pathophysiology. Int J Cardiol Heart Vasc 2021;34:100795. [PMID: 34095448 DOI: 10.1016/j.ijcha.2021.100795] [Cited by in F6Publishing: 1] [Reference Citation Analysis]